•  
  •  
  •  
  •  

2025-10-07 21:29:20

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain

Keywords Selected:  SheelaFoam

Research

  • Management Meet Update - Sheela Foam - ICICI Direct

Stock Report

  • Sheela Foam Ltd reports consolidated PAT of Rs. 21.49 crores in Q4 FY25
  • Sheela Foam Ltd posts consolidated PAT of Rs. 46.01 crores in Q1 FY2025
  • Sheela Foam Limited completes purchase of land
  • Sheela Foam Limited increases stake in Kurlon Enterprise Ltd to 97.23%
  • Sheela Foam Ltd consolidated Q2 FY2023-24 net profit up QoQ at Rs. 44 crores
  • Sheela Foam Ltd raises funds through QIP
  • Sheela Foam Ltd posts consolidated PAT of Rs. 43.06 crores in Q1 FY2023-24
  • Sheela Foam Ltd. acquires Kurl-on & Furlenco Furniture
  • Sheela Foam Limited to acquire Kurlon Enterprise Ltd
  • Sheela Foam Ltd Q4 FY2023 consolidated net profit falls to Rs. 44.81 crores
  • Sheela Foam Ltd Q3FY23 consolidated net profit up QoQ at Rs. 60.53 crores
  • Sheela Foam Ltd allots 4,87,82,808 bonus equity shares
  • Sheela Foam Ltd fixes Dec 22, 2022 as record date for 1:1 bonus issue
  • Sheela Foam Ltd board recommends 1:1 bonus issue
  • Sheela Foam Ltd Q2 FY2022-23 consolidated profit up QoQ at Rs. 53.09 crores
  • Sheela Foam Ltd posts consolidated Q1FY23 PAT of Rs. 42.09 crores
  • Sheela Foam consolidated Q4 FY2022 net profit lower at Rs. 49.23 crores
  • Sheela Foam posts lower consolidated PAT of Rs. 66.87 crores in Q3 FY2021-22
  • Sheela Foam Ltd posts consolidated PAT of Rs. 76.40 crores in Q2 FY22

Latest Post

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Revolt Motors fuels India's Racing Future with Sponsorship of Young Racer Ethan Joy at F4 India Championship
  • Simplex Realty Limited enters into supplemental agreement for redevelopment project
  • Ameenji Rubber Ltd. debuts on BSE SME Exchange
  • Mahanagar Gas Ltd signs MoU with Oil India Ltd to collaborate across the LNG value chain


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024